Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingshu granules for acute gouty arthritis
CTR20233264Phase 3Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Qingshu Granules in gout, sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Oct 2023; status: completed.
02
Drugs
Qingshu Granules
03
Conditions
gout
Beyond the preview
Go deeper on CTR20233264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233264.